Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Nov 12 - Nov 17
Patients recovering from surgery or illness
One emerging treatment option gaining popularity among our clients is GLP-1 medication therapy, such as Ozempic (semaglutide), due to its impressive benefits in weight management, blood sugar control, and overall wellness
10.4155/fmc.12.122 Future Med
Frequently used in receptor signaling and growth factor research models
Patients should contact their healthcare provider promptly if they experience: Severe, persistent abdominal pain that worsens or differs from typical bloating Inability to pass gas or have bowel movements (possible obstruction) Persistent vomiting that prevents adequate hydration or medication adherence Unintentional weight loss beyond expected therapeutic effects Blood in stool or black, tarry stools Fever accompanying gastrointestinal symptoms Right upper quadrant pain or yellowing of skin/eyes (possible gallbladder disease) Severe constipation with abdominal distension (possible ileus/obstruction) Signs of dehydration (excessive thirst, dark urine, dizziness) These symptoms may indicate complications such as pancreatitis, gallbladder disease, bowel obstruction, or acute kidney injuryall noted in FDA prescribing information as potential risks
